TY - JOUR A2 - Teive，Helio公司AU - 费德里科，区文诗 - 迈尔，爱丽丝AU - Vianello，葛丽泰AU - Mapelli，丹妮拉AU - Trentin，MICHELA AU - ZANETTE，Giampietro AU - Picelli，亚历山德罗AU - 甘多尔菲，Marialuisa AU -Tamburin, Stefano PY - 2015 DA - 2015/11/08 TI - Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of the Italian Versions of Three Neuropsychological Tests SP - 681976 VL - 2015 AB - Mild cognitive impairment (MCI) is frequent in Parkinson’s disease (PD). Recently proposed criteria for MCI in PD (PD-MCI) indicate level I diagnosis based on abbreviated assessment and level II based on comprehensive neuropsychological evaluation. The study explored the sensitivity and specificity of the Italian versions of three neuropsychological tests for level I diagnosis of PD-MCI. We recruited 100 consecutive PD patients. After screening for inclusion criteria, 43 patients were included. The sensitivity and specificity of the Mini Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Addenbrooke’s Cognitive Examination Revised (ACE-R) in comparison to level II diagnosis of PD-MCI were examined. PD-MCI was diagnosed (level II) in 51% of patients. Disease duration was significantly longer and PD motor scales were more severely impaired in MCI group. The receiver-operator characteristics curve documented nonsignificant difference in the performance of the three tests, with slight advantage of MMSE (corrected data). The time of administration favored MMSE. In Italian-speaking PD patients, MMSE might represent a good screening tool for PD-MCI, because of the shorter time of administration and the performance comparable to those of MoCA and ACE-R. Further studies are needed to validate the new PD-MCI criteria across different languages and cultures. SN - 2090-8083 UR - https://doi.org/10.1155/2015/681976 DO - 10.1155/2015/681976 JF - Parkinson’s Disease PB - Hindawi Publishing Corporation KW - ER -